주메뉴 바로가기OUT
본문 바로가기
퀵메뉴 바로가기
마이메뉴 바로가기
도서관 정보 바로가기
링크메뉴
주메뉴
소장자료검색
소장자료
Open API
연속간행물검색
기본검색
A-Z
신착자료검색
비도서검색
전체
DVD
고문헌검색
고문헌검색
송광사 고문헌검색
계당 고문헌 검색
학위논문검색
전자자료 통합검색
통합검색
학술DB
국내학술DB
국외학술DB
e-Journal(AtoZ)
eBook/audioBook
eBook
audioBook
대출반납서비스
이용안내
대출/연장/이력/예약
대출도서순위조회
도서신청서비스
희망도서신청
보존서고자료
서가부재도서
분관대출조회
시설이용서비스
스터디룸예약
일반열람실좌석배치도
장애학생 지원서비스
열람실 이용안내
교내 배달서비스
타기관이용서비스
상호대차/원문복사
타기관열람신청
무인예약대출 서비스
이용안내
신청현황 조회
학위논문파일 제출
학위논문제출안내
학위논문제출
개인정보관리
My Page
나의서재
원문복사 신청/조회
이용안내
검색신청
직접신청
신청리스트
상호대차 신청/조회
이용안내
검색신청
직접신청
신청리스트
연구지원서비스
이용안내
서비스신청
신청내역조회
이용교육서비스
교육안내
교육공지 및 신청
신청내역조회
교육자료실
배달서비스
이용안내
신청내역조회
지정도서신청
이용안내
교수별리스트
교과목별리스트
학과별리스트
교과목신청
교과목신청리스트
지정도서신청
Q&A
논문작성지원
EndNote 이용
Turnitin(논문표절예방)이용
CopyKIller(논문표절예방)
도서관가이드
이용안내
학과가이드
서비스가이드
도서관소개
연혁
규정
역대관장
발전계획
도서관사람들
도서관 통계
찾아오는길
이용안내
개관시간
자료분류체계
자료이용안내
이용자별안내
모바일도서관(APP)
시설안내
본관(홍도)안내
별관(백도)안내
정보마루안내
분관안내
지원시설
도서기증/위탁
도서기증 및 위탁안내
게시판
공지사항
학술공지
신착/신간
질의응답
분실물안내
FAQ
전시마당
이달의 고서
전대愛서52
도서관 Gallery
소장자료검색
연속간행물검색
신착자료검색
비도서검색
고문헌검색
학위논문검색
전자자료 통합검색
학술DB
e-Journal(AtoZ)
eBook/audioBook
대출반납서비스
도서신청서비스
시설이용서비스
장애학생 지원서비스
타기관이용서비스
무인예약대출 서비스
학위논문파일 제출
개인정보관리
원문복사 신청/조회
상호대차 신청/조회
연구지원서비스
이용교육서비스
배달서비스
지정도서신청
논문작성지원
도서관가이드
도서관소개
이용안내
시설안내
도서기증/위탁
게시판
전시마당
소장자료검색
연속간행물검색
신착자료검색
비도서검색
고문헌검색
학위논문검색
전자자료 통합검색
학술DB
e-Journal(AtoZ)
eBook/audioBook
대출반납서비스
도서신청서비스
시설이용서비스
장애학생 지원서비스
타기관이용서비스
무인예약대출 서비스
학위논문파일 제출
개인정보관리
원문복사 신청/조회
상호대차 신청/조회
연구지원서비스
이용교육서비스
배달서비스
지정도서신청
논문작성지원
도서관가이드
도서관소개
이용안내
시설안내
도서기증/위탁
게시판
전시마당
도서관안내
시설안내
정보마루안내
4F
전자자료 상세검색
전자자료 상세검색
전자자료 상세검색
통합검색
소장자료
전자자료
통합검색
키워드
전체
저자
제목
주제어
출처
초록
ISSN
ISBN
결과내 검색
검색어
[키워드: "Le Gars, Mathieu"]
총
105
건
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
4/11
페이지
검색결과수정
검색범위확장
Full Text내 키워드 확장
관련 주제어 확장
재검색
검색결과제한
원문(Full Text)
Peer-Reviewed 학술지
발행년
-
재검색
자료유형
Academic Journals
(101)
Magazines
(4)
주제
covid-19
(36)
sars-cov-2
(21)
covid-19 vaccines
(18)
주제
Count
Name
covid-19
(
36
)
sars-cov-2
(
21
)
covid-19 vaccines
(
18
)
vaccine
(
13
)
ad26covs1
(
9
)
immune response
(
7
)
immunoglobulins
(
7
)
vaccination
(
7
)
ad26.cov2.s
(
6
)
pregnancy
(
6
)
immunogenicity
(
5
)
immunogenicity, vaccine
(
5
)
influenza a virus
(
5
)
influenza virus
(
5
)
monocytes
(
5
)
adenovirus diseases
(
4
)
antibodies
(
4
)
antibodies, viral
(
4
)
antibody formation
(
4
)
booster vaccines
(
4
)
cytokines
(
4
)
dendritic cells
(
4
)
efficacy
(
4
)
generalized linear mixed models
(
4
)
generalized linear models
(
4
)
clinical trials
(
3
)
flow cytometry
(
3
)
humans
(
3
)
immunization
(
3
)
innate immunity
(
3
)
plasmacytoid dendritic cells
(
3
)
preexisting immunity
(
3
)
protection
(
3
)
pseudomonas aeruginosa
(
3
)
vaccine efficacy
(
3
)
virus neutralization assay
(
3
)
activation
(
2
)
ad26
(
2
)
anthrax
(
2
)
antibodies, neutralizing
(
2
)
antibody
(
2
)
antigen analysis
(
2
)
bacillus anthracis
(
2
)
cancer cells
(
2
)
cov2
(
2
)
cystic fibrosis transmembrane conductance regulator
(
2
)
enzyme-linked immunosorbent assay
(
2
)
false discovery rate
(
2
)
histocompatibility antigens
(
2
)
humoral immunity
(
2
)
닫기
간행물
journal of infectious diseases
(10)
vaccine
(10)
nature communications
(8)
간행물
Count
Name
journal of infectious diseases
(
10
)
vaccine
(
10
)
nature communications
(
8
)
new england journal of medicine
(
8
)
bmc bioinformatics
(
5
)
iscience
(
5
)
immunological reviews
(
4
)
lancet infectious diseases
(
4
)
nature microbiology
(
4
)
american journal of respiratory and critical care medicine
(
3
)
frontiers in immunology
(
3
)
human vaccines & immunotherapeutics
(
3
)
jama: journal of the american medical association
(
3
)
nature
(
3
)
npj vaccines
(
3
)
proceedings of the national academy of sciences of the united states of america
(
3
)
clinical pharmacology & therapeutics
(
2
)
cpt: pharmacometrics & systems pharmacology
(
2
)
european respiratory journal
(
2
)
jama network open
(
2
)
clinical pharmacology and therapeutics
(
1
)
cpt pharmacometrics systems pharmacology
(
1
)
cpt-pharmacometrics & systems pharmacology
(
1
)
human vaccines immunotherapeutics
(
1
)
jama
(
1
)
jama-journal of the american medical association
(
1
)
journal of immunology
(
1
)
journal of immunology baltimore md 1950
(
1
)
m s-medecine sciences
(
1
)
medecine sciences
(
1
)
medecine sciences m s
(
1
)
medrxiv the preprint server for health sciences
(
1
)
nature: international weekly journal of science
(
1
)
neurology
(
1
)
research square
(
1
)
the journal of infectious diseases
(
1
)
the lancet infectious diseases
(
1
)
the lancet. infectious diseases
(
1
)
닫기
출판사
oxford university press / usa
(6)
american medical association
(5)
elsevier b.v.
(5)
출판사
Count
Name
oxford university press / usa
(
6
)
american medical association
(
5
)
elsevier b.v.
(
5
)
nature publishing group uk
(
5
)
wiley
(
5
)
wiley-blackwell
(
5
)
biomed central
(
4
)
elsevier science
(
4
)
massachusetts medical society
(
4
)
nature portfolio
(
4
)
cell press
(
3
)
elsevier ltd
(
3
)
elsevier sci ltd
(
3
)
escholarship, university of california
(
3
)
amer medical assoc
(
2
)
elsevier inc.
(
2
)
european respiratory soc journals ltd
(
2
)
massachusetts medical soc
(
2
)
nature pub. group
(
2
)
nature publishing group
(
2
)
new england journal of medicine
(
2
)
oxford univ press inc
(
2
)
oxford university press
(
2
)
amer assoc immunologists
(
1
)
amer thoracic soc
(
1
)
american association of immunologists
(
1
)
american thoracic society
(
1
)
blackwell
(
1
)
bmc
(
1
)
edk
(
1
)
edp sciences
(
1
)
edp sciences s a
(
1
)
frontiers media s.a.
(
1
)
frontiers media sa
(
1
)
frontiers research foundation]
(
1
)
lippincott williams & wilkins
(
1
)
national academy of sciences
(
1
)
natl acad sciences
(
1
)
nature research
(
1
)
springer nature
(
1
)
springer nature in partnership with the sealy center for vaccine development
(
1
)
taylor & francis
(
1
)
taylor & francis inc
(
1
)
taylor & francis ltd
(
1
)
닫기
언어
english
(97)
french
(3)
Publication Year
2022
(4)
2021
(3)
2023
(2)
Publication Year
Count
Name
2022
(
4
)
2021
(
3
)
2023
(
2
)
2016
(
1
)
2024
(
1
)
닫기
수록데이터베이스
MEDLINE
(31)
Science Citation Index Expanded
(28)
Academic Search Complete
(11)
수록데이터베이스
Count
Name
MEDLINE
(
31
)
Science Citation Index Expanded
(
28
)
Academic Search Complete
(
11
)
Complementary Index
(
11
)
Springer Nature Journals
(
6
)
CINAHL Plus with Full Text
(
5
)
ScienceDirect
(
5
)
eScholarship
(
3
)
JSTOR Journals
(
2
)
Supplemental Index
(
2
)
Journals@OVID
(
1
)
닫기
PQDT
CAJ
RISS
PsycINFO
전체선택
날짜 내림차순
날짜 오름차순
연관도
10
20
30
50
31
When iNKT cells leave to coal: new therapeutic pathways
학술저널
issue
M S-MEDECINE SCIENCES
; MAY 2017, 33 5, p488-p490, 4p.
Author
Le
Gars
,
Mathieu
Haustant, Michel
Klezovich-Benard, Maria
Paget, Christophe
Trottein, Francois
Goossens, Pierre L.
Tournier, Jean-Nicolas
DB Label
Database : Science Citation Index Expanded
원문보기
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
32
RCT Abstract-Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
학술저널
issue
EUROPEAN RESPIRATORY JOURNAL
; SEP 5 2021, 58 2p. Supplement: 65
Author
Le
Gars
,
Mathieu
Sadoff, Jerald
Shukarev, Georgi
Heerwegh, Dirk
Truyers, Carla
Scheper, Gert
Hendriks, Jenny
Mcelrath, M. Juliana
De Rosa, Stephen
Cohen, Kristen
Douoguih, Macaya
Struyf, Frank
Schuitemaker, Hanneke
DB Label
Database : Science Citation Index Expanded
원문보기
Full Text(ECC)
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
33
RCT Abstract-Ad26.COV2.S immunogenicity in a Phase 2 trial at different booster dose levels and schedule intervals in adults
학술저널
issue
EUROPEAN RESPIRATORY JOURNAL
; SEP 5 2021, 58 2p. Supplement: 65
Author
Cardenas, Vicky
Le
Gars
,
Mathieu
Sadoff, Jerald
Guinazu, Javier Ruiz
Vaissiere, Nathalie
Truyers, Carla
Scheper, Gert
Struyf, Frank
Hendriks, Jenny
Schuitemaker, Hanneke
Douoguih, Macaya
DB Label
Database : Science Citation Index Expanded
원문보기
Full Text(ECC)
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
34
Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination
학술저널
issue
JOURNAL OF IMMUNOLOGY
; OCT 15 2016, 197 8, p3225-p3232, 8p.
Author
Le
Gars
,
Mathieu
Haustant, Michel
Klezovich-Benard, Maria
Paget, Christophe
Trottein, Francois
Goossens, Pierre L.
Tournier, Jean-Nicolas
DB Label
Database : Science Citation Index Expanded
원문보기
Full Text(ECC)
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
원문복사신청 - FRIC
35
Toll-like receptor 5 (TLR5), IL-1 beta secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing
학술저널
issue
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
; JAN 31 2012, 109 5, p1619-p1624, 6p.
Author
Descamps, Delphyne
Le
Gars
,
Mathieu
Balloy, Viviane
Barbier, Diane
Maschalidi, Sophia
Tohme, Mira
Chignard, Michel
Ramphal, Reuben
Manoury, Benedicte
Sallenave, Jean-Michel
DB Label
Database : Science Citation Index Expanded
원문보기
Full Text (PNAS)
Full Text (JSTOR)
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
원문복사신청 - FRIC
36
Quand les cellules iNKT partent au charbon : nouvelles pistes thérapeutiques. (French)
iNKT cells: potential therapeutic targets to fight anthrax. (English)
학술저널
issue
Médecine Sciences; 2017, Vol. 33 Issue 5, p488-490, 3p
Author
Le
Gars
,
Mathieu
Haustant, Michel
Klezovich-Benard, Maria
Paget, Christophe
Trottein, François
Goossens, Pierre L.
Tournier, Jean-Nicolas
DB Label
Database : Complementary Index
원문보기
등재 - Web of Science (SCIE)
등재 - SCOPUS
조회 - Impact Factor (JCR)
37
Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry
학술저널
issue
NEUROLOGY
; APR 10 2018, 90 2p. Supplement: 15
Author
Ranganath, Thanmayi
Seiler, Christof
Vendrame, Elena
Le
Gars
,
Mathieu
Fontenot, Jason D.
Fam, Sami
Holmes, Susan
Blish, Catherine
DB Label
Database : Science Citation Index Expanded
원문보기
등재 - Web of Science
등재 - SCOPUS
조회 - Impact Factor (JCR)
원문복사신청 - FRIC
38
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
issue
Research square
[Res Sq] 2023 May 31.
Date of Electronic Publication:
2023 May 31.
Author
Magaret C
; Fred Hutchinson Cancer Center.
Li L
; Fred Hutchinson Cancer Center.
deCamp A
; Fred Hutchinson Cancer Center.
Rolland M
; MHRP-HJF.
Juraska M
; Fred Hutchinson Cancer Center.
Williamson B
; Kaiser Permanente Washington Health Research Institute.
Ludwig J
; Fred Hutchinson Cancer Center.
Molitor C
; Fred Hutchinson Cancer Center.
Benkeser D
; Emory.
Luedtke A
; University of Washington.
Simpkins B
; Pitzer College.
Carpp L
; Fred Hutchinson Cancer Center.
Bai H
; WRAIR.
Deariove B
; Walter Reed Army Institute of Research.
Greninger A
; University of Washington.
Roychoudhury P
; University of Washington.
Sadoff J
; Janssen Research & Development, LLC.
Gray G
; South African Medical Research Council.
Roels S
; Janssen R&D.
Vandebosch A
; Janssen R&D.
Stieh D
; Janssen Vaccines & Prevention BV.
Le
Gars
M
; Janssen Vaccines and Prevention B.V.
Vingerhoets J
; Janssen Pharmaceutica N.V., Beerse, Belgium.
Grinsztejn B
; Evandro Chagas National Institute of Infectious Diseases-Fundacao Oswaldo Cruz.
Goepfert P
; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham.
Truyers C
; Janssen Pharmaceutica N.V., Beerse, Belgium.
Van Dromme I
; Janssen R&D, a division of Janssen Pharmaceutica NV.
Swann E
; NIAID/NIH.
Marovich M
; National Institute of Allergy and Infectious Diseases.
Follmann D
; National Institutes of Health.
Neuzil K
; University of Maryland School of Medicine.
Corey L
; Fred Hutchinson Cancer Center.
Hyrien O
; Fred Hutchinson Cancer Research Center.
Paiva de Sousa L
; Evandro Chagas National Institute of Infectious Diseases-Fundacao Oswaldo Cruz.
Casapia M
; Asociación Civil Selva Amazónica.
Losso M
; Hospital General de Agudos José María Ramos Mejia.
Little S
; Department of Medicine, University of California, San Diego, CA 92903.
Gaur A
; St. Jude Children's Research Hospital.
Bekker LG
; Desmond Tutu HIV centre.
Garrett N
; Centre for the AIDS Program of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa 4041.
Heng F
; University of North Florida.
Sun Y
; University of North Carolina at Charlotte.
Gilbert P
; Fred Hutchinson Cancer Center.
DB Label
Database : MEDLINE
39
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
학술저널
issue
The New England journal of medicine
[N Engl J Med] 2022 Mar 03; Vol. 386 (9), pp. 847-860.
Date of Electronic Publication:
2022 Feb 09.
Author
Sadoff J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Gray G
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Vandebosch A
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Cárdenas V
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Shukarev G
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Grinsztejn B
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Goepfert PA
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Truyers C
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Van Dromme I
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Spiessens B
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Vingerhoets J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Custers J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Scheper G
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Robb ML
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Treanor J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Ryser MF
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Barouch DH
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Swann E
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Marovich MA
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Neuzil KM
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Corey L
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Stoddard J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Hardt K
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Ruiz-Guiñazú J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Le
Gars
M
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Schuitemaker H
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Van Hoof J
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Struyf F
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
Douoguih M
; From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) - all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)
등재 - SCOPUS
조회 - Impact Factor (JCR)
40
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
issue
MedRxiv : the preprint server for health sciences
[medRxiv] 2021 Jul 07.
Date of Electronic Publication:
2021 Jul 07.
Author
Barouch DH
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Stephenson KE
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Sadoff J
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
Yu J
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Chang A
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Gebre M
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
McMahan K
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Liu J
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Chandrashekar A
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Patel S
; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Le
Gars
M
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
de Groot AM
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
Heerwegh D
; Janssen Research & Development, Beerse, Belgium.
Struyf F
; Janssen Research & Development, Beerse, Belgium.
Douoguih M
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
van Hoof J
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
Schuitemaker H
; Janssen Vaccines & Prevention, Leiden, The Netherlands.
DB Label
Database : MEDLINE
1
2
3
4
5
바구니보기
172861
128230289
대학도서관
RISS-한국교육학술정보원
LG 상남도서관
가톨릭대학교 도서관
강남대학교 도서관
강릉대학교 도서관
강원대학교 삼척캠퍼스 도서관
강원대학교 중앙도서관
건국대학교 상허기념도서관
경기대학교 중앙도서관
경남과학기술대학교 도서관
경남대학교 중앙도서관
경북대학교 도서관
경상대학교 중앙도서관
경성대학교 중앙도서관
경인교육대학교 도서관
경희대학교 도서관
계명대학교 동산도서관
고려대학교 중앙도서관
고신대학교 중앙도서관
공주교육대학교 디지털도서관
공주대학교 중앙도서관
관동대학교 중앙도서관
광운대학교 중앙도서관
광주과학기술원 도서관
광주교육대학교 디지털도서관
광주대학교 중앙도서관
국가전자도서관
국립중앙도서관
국민대학교 성곡도서관
국회도서관
군산대학교 중앙도서관
금오공과대학교 도서관
남서울대학교 중앙도서관
단국대학교 율곡기념도서관
단국대학교 퇴계기념중앙도서관
대구가톨릭대학교 중앙도서관
덕성여자대학교 중앙도서관
동국대학교 도서관
동덕여자대학교 중앙도서관
동신대학교 중앙도서관
동아대학교 중앙도서관
동의대학교 중앙도서관
명지대학교 도서관
목원대학교 중앙도서관
목포대학교 중앙도서관
배재대학교 중앙도서관
부경대학교 도서관
부산교육대학교 학술정보관
부산대학교 도서관
부산외국어대학교 도서관
삼육대학교 도서관
상명대학교 중앙도서관
상지대학교 학술정보원
서강대학교 로욜라도서관
서울과학기술대학교 도서관
서울교육대학교 디지털도서관
서울대학교 농학도서관
서울대학교 사회과학도서관
서울대학교 중앙도서관
서울시립대학교 중앙도서관
서울신학대학교 도서관
서울여자대학교 중앙도서관
서원대학교 학술정보원
성결대학교 학술정보관
성공회대학교 중앙도서관
성균관대학교 학술정보관
성신여자대학교 중앙도서관
세종대학교 학술정보원
송원대학교
수리과학연구정보센터
수원대학교 중앙도서관
숙명여자대학교 도서관
순천대학교 중앙도서관
순천향대학교 향설기념 중앙도서관
숭실대학교 중앙도서관
신라대학교 도서관
아주대학교 중앙도서관
안동대학교 중앙도서관
연세대학교 의학도서관
연세대학교 학술정보원
영남대학교 중앙도서관
영동대학교 중앙도서관
우석대학교 중앙도서관
울산대학교 중앙도서관
원광대학교 중앙도서관
월계문화정보도서관
위덕대학교 회당학술정보원
이화여자대학교 중앙도서관
인덕대학 도서관
인제대학교 백인제기념도서관
인천대학교 학산도서관
인하대학교 정석학술정보관
장로회신학대학교 도서관
전남대학교 여수캠퍼스 도서관
전북대학교 중앙도서관
전주교육대학교 디지털도서관
전주대학교 중앙도서관
제주대학교 중앙도서관
조선대학교 중앙도서관
중앙대학교 서울캠퍼스 중앙도서관
중앙대학교 안성캠퍼스 중앙도서관
진주교육대학교 도서관
창원대학교 중앙도서관
청주대학교 중앙도서관
추계예술대학교 전자정보도서관
충남대학교 디지털도서관
충북대학교 도서관
포항공과대학교 청암학술정보관
한국과학기술원 전자도서관
한국교원대학교 도서관
한국기술교육대학교 다산정보관
한국외국어대학교 도서관
한국체육대학교 학술정보시스템
한국해양대학교 도서관
한남대학교 학술정보관
한동대학교 학술정보관
한림대학교 일송기념도서관
한밭대학교 도서관
한서대학교 중앙도서관
한성대학교 학술정보관
한양대학교 백남학술정보관
한양대학교 안산학술정보관
호남대학교 중앙도서관
홍익대학교 중앙도서관
화순전남대병원의학도서실
참고정보원
RISS-한국교육학술정보원
NDSL 과학기술정보통합서비스
건설연구정보센터(서울대학교)
과학기술정책연구원(STEPI)
광주과학기술원(K-JIST)
국내의학학술지 초록검색
기계공학연구정보센터(부산대학교)
농생명과학연구정보센터(서울대학교)
대외경제정책연구원(KIEP)
물리학연구정보센터(서울대학교)
보건연구정보센터(전남대학교)
생물학연구정보센터(포항공과대학교)
의약연구정보센터(숙명여자대학교)
의학연구정보센터(충북대학교)
재료연구정보센터(경북대학교)
테크노경영연구정보센터
한국과학기술연구원(KIST)
한국과학기술원(KAIST)
한국과학기술정보연구원(KISTI)
한국교육개발원(KEDI)
한국기계연구원(KIMM)
한국기초과학지원연구원(KBSI)
한국문화예술진흥원(KCAF)
한국생명공학연구원(KRIBB)
한국에너지기술연구원(KIER)
한국원자력연구원(KAERI)
한국전기연구원(KERI)
한국전자통신연구원(ETRI)
한국지질자원연구원(KIGAM)
한국표준과학연구원(KRISS)
한국항공우주연구원(KARI)
한국해양연구원(KORDI)
한국화학연구원(KRICT)
한국환경정책평가연구원
화학공학연구정보센터(고려대학교)
환경지질연구정보센터(연세대학교)